NRX Pharmaceuticals's total assets for Q2 2024 were $5.26M, an increase of 38.97% from the previous quarter. NRXP total liabilities were $23.66M for the fiscal quarter, a 25.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.